Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

RSS icon
artificial intelligence consultation

Deep learning in cardiovascular imaging: 4 key takeaways for cardiologists

More and more AI algorithms are being trained to learn, think and act like a human physician. What does this mean for the future of cardiovascular imaging as time goes on?

Arineta Cardio Imaging cardiovascular CT scanners AI

FDA clears AI-powered image reconstruction technology for cardiac CT scanners

The new technology, trained using more than 3 billion data points, was designed to reduce image noise and improve the overall quality of CT scans. 

Prosthesis-patient mismatch (PPM) after TAVR

Cardiologists may want to rethink how they track prosthesis-patient mismatch after TAVR

Researchers evaluated two techniques for predicting PPM after TAVR, comparing them to how cardiologists typically check for PPM in day-to-day practice. 

Thumbnail

Downstream costs of noninvasive cardiac diagnostics revealed in data study

At what looks to be an 18% cost savings downstream, stress echocardiograms looks to be the least expensive diagnostic procedure for patients with chest pain

Somatom Pro.Pulse CT machine.

Siemens Healthineers unveils smaller dual source CT machine, designed for rural areas

The Somatom Pro.Pulse consumes 20% less power when compared to larger machines, reducing costs for healthcare organizations.

artificial intelligence AI heart cardiology

ChatGPT struggles with echocardiography, but still shows potential to help cardiology trainees

ChatGPT may not be quite ready to help prepare trainees for their next echocardiography exam—but it does show promise. 

Jamie Bourque, MD, discusses fluorodeoxyglucose (FDG) and its growing use cases in cardiac PET imaging He discussed the radiotracer in sessions at ASNC 2023. #ASNC #ASNC23 #ASNC2023

The expanding scope of FDG-PET in nuclear cardiac imaging

Jamie Bourque, MD, spoke to Cardiovascular Business about the growing number of ways FDG-PET scans are being used in cardiology. This includes evaluating inflammation, tracking EP device infections and much more. 

Ramon Varcoe explains the LIFE-BTK trial for the Abbott Esprit fully bioresobable scaffold at TCT23.

Fully bioresorbable stents boost care for CLI patients in LIFE-BTK trial

Ramon Varcoe, MBBS, co-principal investigator for the LIFE-BTK trial, discussed the results with Cardiovascular Business at TCT 2023. "I can't wait to start using these in my patients. It's going to make a huge difference."

Displaying 377 - 384 of 1685
Design by Adaptive Theme